"Pneumonia No. 1" Commissioned A Pharmaceutical Production Was Approved Quickly For 30 Designated Hospitals In Guangdong.

The "pneumonia No. 1" developed by the Eighth People's Hospital of Guangzhou has attracted much attention. "Pneumonia No. 1" is actually a traditional Chinese medicine preparation, which is based on the experience of preventing and curing SARS epidemic in 2003.

At present, the drug has been entrusted to the Guangdong one Pharmaceutical Co., Ltd. (hereinafter referred to as "one side pharmaceutical") production and preparation. One side pharmaceutical belongs to the China Pharmaceutical Holdings Limited. Qixin Bao shows that one party pharmaceutical is owned by Jiangyin Tian Jiang Pharmaceutical Co., Ltd. 100%, and the Chinese Medicine Holdings Limited is the ultimate beneficiary holding 81.8% stake in the pharmaceutical company. One side pharmaceuticals said that the company has already done the preparatory work related to production.

In February 8th, the official website of the Guangdong provincial drug administration released the latest news. It agreed with the Guangzhou Eighth People's Hospital's declared "Qu Fang Qu Wen Granule" (formerly known as "pneumonia No. 1"), which was used for the treatment of 30 new-type coronavirus infected pneumonia in the whole province. The application of dispensing in non designated hospitals will be given priority by the provincial drug administration.

Granule for clearing away the expelling particles (Ceng Yongming: "pneumonia No. 1 recipe") is the clinical experience of the Chinese medicine practitioner of the Department of traditional Chinese medicine of the Eighth People's Hospital of Guangzhou. Director Tan Hanghua is a famous Chinese medicine in Guangdong province. Under the guidance of the theory of epidemic febrile diseases, Professor Peng Shengquan, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, is under the guidance of the theory of epidemic febrile diseases. He formulated the TCM treatment of new type of coronavirus infection pneumonia, namely, "clearing away heat and detoxicating, dispersing wind and clearing the exterior, and supplementing qi and nourishing Yin". "Tan Hanghua"

The validity period is tentatively scheduled for 6 months.

The time limit for entrustment of the hospital preparation to April 3, 2020 is only 2 months, and the validity period of the preparation is tentatively fixed for 6 months. "Pneumonia No. 1" is used as a hospital preparation in the eight hospital of the city. However, during the special period, the provincial food and Drug Administration specially approved the product for clinical application in designated hospitals in the province. It is reported that "pneumonia No. 1" involves a total of 16 traditional Chinese medicines, and the production cycle is about one week.

The "pneumonia No. 1" is a special hospital preparation prepared by the Guangdong provincial drug administration. It can not be used in other areas temporarily.

The prescription is recommended for two times a day, two packets per day under the guidance of the hospital. Generally recommended for two weeks. The production period of "pneumonia No. 1" product is about a week, and the production is entrusted to one side pharmacy. According to the previous clinical experience, "pneumonia No. 1" has already had a successful case.

On the afternoon of February 6th, the first confirmed case of pneumonia caused by a new coronavirus in Guangzhou was cured and discharged in the Eighth People's Hospital of Guangzhou.

It is understood that in January 13th, Ms. Cheng, who lived in Wuhan, had symptoms of low fever, dry cough and fatigue. 16 of the schedule women felt that the symptoms were aggravated. On the evening of January 19th, she came to Guangzhou for treatment by train, and the next day she went to Guangzhou No.1 People's Hospital fever clinic. The fever clinic gave her lung CT, which showed that she was infected with the virus. Combined with Wuhan's residence history, doctors immediately transferred it to the Eighth People's Hospital of Guangzhou for further diagnosis.

Chen Lingzhen, chief physician of Guangzhou Eighth People's Hospital, introduced to reporters including the twenty-first Century economic report. After receiving the patient, she immediately arranged throat swabs for her, and the results were positive. "We treated her with antiviral treatment, and also used pneumonia 1 Prescription Chinese medicine. Because of mild illness, the patient's condition soon improved. In January 27th, 31 and February 3rd, the three swabs were all negative and lung imaging was transferred. We assessed that she had reached the discharge standard.

The notice issued by the provincial drug administration, the health protection committee and the Chinese medicine bureau mentioned that the Eighth People's Hospital of Guangzhou is the main body responsible for the preparation of granules for medical treatment, and should pay close attention to the adverse reactions that may occur during the use of the preparations, and take effective risk control measures. If the medical institutions that use the preparation have adverse reactions during the use, they should be submitted to the provincial ADR monitoring center and the Eighth People's Hospital of Guangzhou.

Earlier, the Guangdong Provincial Drug Administration issued a news report on its official website in February 1st. The provincial drug administration intends to include the preparation of "pneumonia No. 1 party" for the medical institutions of Guangzhou Eighth People's hospital to be submitted for emergency examination and approval.

Guangdong Provincial Drug Administration said, "pneumonia No. 1" in the Eighth People's Hospital of Guangzhou City, the new coronavirus infection pneumonia treatment showed: treatment of new coronavirus infection mild pneumonia confirmed 50 cases, after 1 weeks of clinical observation, all patients returned to normal temperature, 50% patients cough symptoms disappeared, 52.4% symptoms of sore throat disappeared, 69.6% asthenia symptoms disappeared, the overall symptoms were obvious. After improvement, no patient turned to severe illness. "After the expert discussion, it is considered that the" pneumonia No. 1 "can significantly improve the clinical symptoms of pneumonia caused by mild new coronavirus, and has a tendency to reduce the incidence of severe pneumonia and has good clinical value.

Exploration of Chinese medicine against "new crown"

Pneumonia No. 1, as one of the representatives of the anti new crown, plays a corresponding role.

Tan Hanghua, director of Department of traditional Chinese medicine, Eighth People's Hospital of Guangzhou, said in a media interview in February 3rd that "pneumonia No. 1" is only suitable for mild and suspected patients, and is not suitable for critically ill patients. Besides, prescription can not be used as a preventive prescription. It is suggested that patients should be used in hospitals because there may be some clinical adverse reactions, including the increase of stool frequency after the use of prescriptions. However, he also stressed that from the existing clinical observation, the number of stools decreased gradually after one day of using the prescription.

Tan Hanghua said, "pneumonia No. 1" is based on the experience of preventing and controlling SARS accumulation. From the perspective of traditional Chinese medicine, SARS virus and new coronavirus belong to the category of "epidemic febrile disease", but there are certain differences between Guangzhou and Wuhan. Wuhan is mainly cold and dampness, and Guangzhou is mainly wind heat. Therefore, in the treatment, we should focus on clearing away heat and detoxicating, relieving cough and eliminating phlegm, dispersing wind and dissipating heat, and supplementing qi and nourishing yin. This is the formulation principle of "pneumonia No. 1".

On February 3rd, at the special press conference of the Central Steering Group on medical treatment held in Hubei, Zhang Boli, member of the expert group of the national health and Health Committee, academician of the Chinese Academy of engineering and President of Tianjin University of Traditional Chinese Medicine, said that the mild and moderate patients with new pneumonia were easy to recover after treatment by traditional Chinese medicine, and the conversion of moderate patients to severe cases was significantly reduced. Oxygen saturation and improvement of dyspnea have certain auxiliary therapeutic effects.

However, academician Zhang Boli also stressed that "Chinese medicine treatment is not aimed at viruses, but also regulates the immune status of the body."

Prior to this, Zhong Nanshan, director of the Chinese Academy of engineering and director of the National Center for respiratory diseases clinical medical research, talked about the diagnosis and treatment of pneumonia by Chinese medicine. He said: "scientific research is the support, so we have to do a lot of scientific research work, but we can not observe the strict randomized control in the past, but observe some new treatment methods in the medical process. We are also considering the role of Chinese medicine. Chinese medicine must intervene at the very beginning. This is what we do in Guangdong and do it in many places. "

Generally speaking, the role of traditional Chinese medicine is more in regulating the body and preventing diseases. In the diagnosis and treatment of specific diseases, traditional Chinese medicine is usually not as effective as innovative drugs. Zhang Boli's judgment on the diagnosis and treatment of new pneumonia by Chinese medicine is: "Chinese medicine is symptomatic treatment, and Chinese medicine treatment is not aimed at viruses, but more is the regulation of the immune state of the body."

?